192 related articles for article (PubMed ID: 25975233)
1. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
[TBL] [Abstract][Full Text] [Related]
2. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer.
Yun SJ; Jeong P; Kim WT; Kim TH; Lee YS; Song PH; Choi YH; Kim IY; Moon SK; Kim WJ
Int J Oncol; 2012 Nov; 41(5):1871-8. PubMed ID: 22961325
[TBL] [Abstract][Full Text] [Related]
3. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
4. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
[TBL] [Abstract][Full Text] [Related]
6. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
Lin R; Shen W; Zhi Y; Zhou Z
Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
[TBL] [Abstract][Full Text] [Related]
9. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
Yamada Y; Enokida H; Kojima S; Kawakami K; Chiyomaru T; Tatarano S; Yoshino H; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Cancer Sci; 2011 Mar; 102(3):522-9. PubMed ID: 21166959
[TBL] [Abstract][Full Text] [Related]
10. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
[TBL] [Abstract][Full Text] [Related]
11. Identification of urinary hsa_circ _0137439 as potential biomarker and tumor regulator of bladder cancer.
Song Z; Zhang Q; Zhu J; Yin G; Lin L; Liang C
Neoplasma; 2020 Jan; 67(1):137-146. PubMed ID: 31777254
[TBL] [Abstract][Full Text] [Related]
12. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
Tölle A; Jung M; Rabenhorst S; Kilic E; Jung K; Weikert S
Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNAs in the urine of patients with bladder cancer.
Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
[TBL] [Abstract][Full Text] [Related]
14. Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Du L; Jiang X; Duan W; Wang R; Wang L; Zheng G; Yan K; Wang L; Li J; Zhang X; Pan H; Yang Y; Wang C
Oncotarget; 2017 Jun; 8(25):40832-40842. PubMed ID: 28388561
[TBL] [Abstract][Full Text] [Related]
15. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
[TBL] [Abstract][Full Text] [Related]
16. Is urinary soluble Fas an independent predictor of non-muscle-invasive bladder cancer? A prospective chart study.
Yang H; Li H; Wang Z; Gao J; Guo Y
Urol Int; 2013; 91(4):456-61. PubMed ID: 23948854
[TBL] [Abstract][Full Text] [Related]
17. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.
Hanke M; Hoefig K; Merz H; Feller AC; Kausch I; Jocham D; Warnecke JM; Sczakiel G
Urol Oncol; 2010; 28(6):655-61. PubMed ID: 19375957
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
Ding W; Gou Y; Sun C; Xia G; Wang H; Chen Z; Tan J; Xu K; Qiang D
Urol Oncol; 2014 Jan; 32(1):42.e13-9. PubMed ID: 24360660
[TBL] [Abstract][Full Text] [Related]
19. Validation study of a noninvasive urine test for diagnosis and prognosis assessment of bladder cancer: evidence for improved models.
Mengual L; Ribal MJ; Lozano JJ; Ingelmo-Torres M; Burset M; Fernández PL; Alcaraz A
J Urol; 2014 Jan; 191(1):261-9. PubMed ID: 23831312
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis.
Eissa S; Matboli M; Hegazy MG; Kotb YM; Essawy NO
Transl Res; 2015 Jun; 165(6):731-9. PubMed ID: 25620614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]